Erste Asset Management GmbH
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 2024532
VIENNA, C4
Position in VRTX
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$41,062,925
+$10,523,236 QoQ
Shares Held
91,958
+36.5% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.08444471572008.ToString("F0")%
Shared 0.ToString("F0")%
None 0.9155552842799157.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Erste Asset Management GmbH holds $563,481,319 across 72 Biotechnology names. VRTX ranks #5 (7.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AGIO |
Agios Pharmaceuticals, Inc.
|
2,704,900 | $91,506,767 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
160,210 | $83,865,128 | |
| 3 | SRPT |
Sarepta Therapeutics, Inc.
|
2,968,945 | $64,604,243 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
57,209 | $44,201,961 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
91,958 | $41,062,925 | |
| 6 | MIRM |
Mirum Pharmaceuticals, Inc.
|
210,000 | $19,399,800 | |
| 7 | REPL |
Replimune Group, Inc.
|
2,120,000 | $16,218,000 | |
| 8 | STOK |
Stoke Therapeutics, Inc.
|
446,000 | $14,521,760 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $41,062,925 | 91,958 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $30,539,689 | 67,363 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $26,442,357 | 67,517 | Shares | Other | 2025-11-12 | |
| 2025-06-30 | $32,901,615 | 73,903 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $33,341,071 | 68,770 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $26,487,189 | 65,774 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $29,539,091 | 63,514 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $27,329,188 | 58,306 | Shares | Sole | 2024-11-26 | |
| 2024-03-31 | $27,880,430 | 66,698 | Shares | Sole | 2024-11-26 | |
| 2023-12-31 | $45,543,604 | 111,931 | Shares | Sole | 2024-11-26 | |
| 2023-09-30 | $40,068,341 | 115,225 | Shares | Sole | 2024-11-26 | |
| 2023-06-30 | $29,234,923 | 83,075 | Shares | Sole | 2024-11-26 | |
| 2023-03-31 | $27,326,021 | 86,730 | Shares | Sole | 2024-11-26 | |
| 2022-12-31 | $23,717,501 | 82,130 | Shares | Sole | 2024-11-26 | |
| 2022-09-30 | $23,893,709 | 82,523 | Shares | Sole | 2024-11-26 | |
| 2022-06-30 | $23,888,183 | 84,773 | Shares | Sole | 2024-11-26 | |
| 2022-03-31 | $21,921,480 | 84,000 | Shares | Sole | 2024-11-25 | |
| 2021-12-31 | $13,439,520 | 61,200 | Shares | Sole | 2024-11-25 | |
| 2021-09-30 | $11,246,180 | 62,000 | Shares | Sole | 2024-11-25 | |
| 2021-06-30 | $12,501,060 | 62,000 | Shares | Sole | 2024-11-25 | |
| 2021-03-31 | $14,964,939 | 69,640 | Shares | Sole | 2024-11-25 | |
| 2020-12-31 | $16,458,717 | 69,640 | Shares | Sole | 2024-11-25 | |
| 2020-09-30 | $16,844,772 | 61,902 | Shares | Sole | 2024-11-25 | |
| 2020-06-30 | $19,929,781 | 68,650 | Shares | Sole | 2024-11-22 | |
| 2020-03-31 | $21,748,630 | 91,400 | Shares | Sole | 2024-11-22 | |
| No filing history on record for this holder in this stock. | ||||||